Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare malignant hepatic cancer with characteristics that differ from those of typical hepatocellular carcinoma (HCC). Unlike conventional HCC, FLHCC is common in young patients without any underlying liver disease and is known to be associated with a unique gene mutation. This cancer type is rare in Asia, with only a few cases being reported in Korea. We report a case of FLHCC in a young woman that successfully underwent surgical resection. The efficacy of alternative treatments, such as transarterial chemoembolization or systemic chemotherapies, has not yet been established. To conclude, early diagnosis and appropriate surgical resection are important for the treatment of FLHCC.
Citations
Citations to this article as recorded by
Fibrolamellar Hepatocellular Carcinoma (FLHCC) in a Young Patient Presenting With Nausea and Vomiting After a Greasy Meal Mohamed Ismail , Sahiba Singh, Menna-Allah Elaskandrany , David s Kim, Yazan Abboud, Michael Bebawy, Abena Oduro, Ritik mahaveer Goyal, Omar Mohamed , Weizheng Wang Cureus.2024;[Epub] CrossRef
Fibrolamellar hepatocellular carcinoma (FL-HCC) is relatively rare, with only two cases reported in Korean literature. Four cases (1.4% : 4/282) with typical FL-HCC underwent partial hepatectomies in Ajou University Hospital from July 1994 through January 2003. We report these cases with a review of related literatures.
Fibrolamellar hepatocellular carcinoma (FL-HCC) is relatively rare, with only two cases reported in Korean literature. Four cases (1.4%:4/282) with typical FL-HCC underwent partial hepatectomies in Ajou University Hospital from July 1994 through January 2003. We report these cases with a review of related literatures.